New Key Statistics Module, Z-Score and F-Score
NEOE:PFE Key Ratios
Market Cap C$ M | 215,267.36 |
Enterprise Value C$ M | 295,080.45 |
P/E(ttm) | -- |
PE Ratio without NRI | 22.84 |
Forward PE Ratio | 12.42 |
Price/Book | 1.76 |
Price/Sales | 2.85 |
Price/Free Cash Flow | 32.44 |
Price/Owner Earnings | 432.81 |
Payout Ratio % | 1.25 |
Revenue (TTM) C$ M | 74,077.00 |
EPS (TTM) C$ | -0.03 |
Beneish M-Score | -2.35 |
10-y EBITDA Growth Rate % | 2.10 |
5-y EBITDA Growth Rate % | 8.10 |
y-y EBITDA Growth Rate % | -76.30 |
EV-to-EBIT | 241.58 |
EV-to-EBITDA | 30.71 |
PEG | 2.82 |
Shares Outstanding M | 14,709.59 |
Net Margin (%) | -0.56 |
Operating Margin % | 2.16 |
Pre-tax Margin (%) | -3.25 |
Quick Ratio | 0.69 |
Current Ratio | 0.91 |
ROA % (ttm) | -0.15 |
ROE % (ttm) | -0.32 |
ROIC % (ttm) | 0.09 |
Dividend Yield % | 6.03 |
Altman Z-Score | 1.70 |
NEOE:PFE Number of Guru Trades
NEOE:PFE Volume of Guru Trades
Gurus Latest Trades with NEOE:PFE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NEOE:PFE is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Pfizer Inc Insider Transactions
No Available Data